Maximum Civil Money Penalty Amounts and Compliance With the Federal Civil Penalties Inflation Adjustment Act; Confirmation of Effective Date, 8200 [E9-3831]

Download as PDF 8200 Federal Register / Vol. 74, No. 35 / Tuesday, February 24, 2009 / Rules and Regulations State Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming Wyoming FOR FURTHER INFORMATION CONTACT: Erik Mettler, Office of Policy, Food and Drug Administration, 10903 New Hampshire $11.55 Ave, Bldg. 1, rm. 4305, Silver Spring, $5.78 MD 20993, 301–796–4830. $11.55 ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... ....... DEPARTMENT OF THE TREASURY $5.78 $5.78 $5.78 $23.10 $5.78 $5.78 $23.10 $11.55 $11.55 $23.10 $5.78 $69.31 $11.55 $11.55 $5.78 [TD 9447] (Fee/acre/ yr) County Crook ............. Fremont ......... Goshen .......... Hot Springs .... Johnson ......... Laramie .......... Lincoln ........... Natrona .......... Niobrara ......... Park ............... Platte .............. Sheridan ........ Sublette .......... Sweetwater .... Teton .............. Uinta .............. Washakie ....... Weston ........... * State-average Land and Building value used where no county-specific value is available. ** Land areas to be determined. [FR Doc. E9–3788 Filed 2–23–09; 8:45 am] BILLING CODE 6717–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 17 [Docket No. FDA–2008–N–0561] Maximum Civil Money Penalty Amounts and Compliance With the Federal Civil Penalties Inflation Adjustment Act; Confirmation of Effective Date AGENCY: Food and Drug Administration, HHS. mstockstill on PROD1PC66 with RULES ACTION: Direct final rule; confirmation of effective date. SUMMARY: The Food and Drug Administration (FDA) is confirming the effective date of March 27, 2009, for the direct final rule that appeared in the Federal Register of November 12, 2008 (73 FR 66750). The direct final rule amends the agency’s regulations to update the statutory citations regarding the new civil monetary penalties prescribed by the Food and Drug Administration Amendments Act of 2007 (FDAAA), amends the regulations to include the new FDAAA penalties, and adjusts the preceding maximum civil penalty amounts for inflation as prescribed by the Federal Civil Penalties Inflation Adjustment Act of 1990 (FCPIAA). This document confirms the effective date of the direct final rule. DATES: Effective date confirmed: March 27,2009. VerDate Nov<24>2008 16:27 Feb 23, 2009 Jkt 217001 In the Federal Register of November 12, 2008 (73 FR 66750), FDA published the ‘‘Maximum Civil Money Penalty Amounts and Compliance With the Federal Civil Penalties Inflation Adjustment Act’’ direct final rule and solicited comments concerning the direct final rule for a 75-day period ending March 27, 2009. The direct final rule revises § 17.1 (21 CFR 17.1) to update the statutory citations regarding the new civil monetary penalties prescribed by FDAAA, and revises the table in § 17.2 (21 CFR 17.2) to include the new FDAAA penalties, and adjusts the preceding maximum civil penalty amounts for inflation as prescribed by the FCPIAA. This was accomplished by revising the list of statutory monetary penalties in § 17.1 to include the new penalties prescribed by the Federal Food, Drug, and Cosmetic Act, as amended by FDAAA in 2007. These new penalties have been added as new paragraphs (c) and (d). The table in § 17.2 also has been amended to include the new penalties, and the adjusted maximum penalty amounts for the preFDAAA penalties have been updated to account for the inflation between June 2004 (the year of the last adjustment) and June 2007 as prescribed by FCPIAA. FDA also solicited comments concerning the changes for a 75-day period ending January 26, 2009, in a proposed rule published in the Federal Register of November 12, 2008 (73 FR 66811). FDA stated that the effective date of the direct final rule would be on March 27, 2009, 60 days after the end of the comment period, unless any significant adverse comment was submitted to FDA during the comment period. FDA did not receive any significant adverse comments. Authority: Therefore, under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act, and under authority delegated to the Commissioner of Food and Drugs, 21 CFR part 17 is amended. Accordingly, the amendments issued thereby are effective. SUPPLEMENTARY INFORMATION: Dated: February 17, 2009. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E9–3831 Filed 2–23–09; 8:45 am] BILLING CODE 4160–01–S PO 00000 Frm 00060 Fmt 4700 Sfmt 4700 Internal Revenue Service 26 CFR Parts 1 and 54 RIN 1545–BG80 Automatic Contribution Arrangements AGENCY: Internal Revenue Service (IRS), Treasury. ACTION: Final regulations. SUMMARY: This document contains final regulations relating to automatic contribution arrangements. These regulations affect administrators of, employers maintaining, participants in, and beneficiaries of section 401(k) plans and other eligible plans that include an automatic contribution arrangement. DATES: Effective date: These regulations are effective on February 24, 2009. Applicability date: Except as provided in §§ 1.401(k)–3(j)(1)(i) and 1.401(m)– 2(a)(6)(ii), the final regulations relating to qualified automatic contribution arrangements (§§ 1.401(k)–2, 1.401(k)–3, 1.401(m)–2, and 1.401(m)–3) apply to plan years beginning on or after January 1, 2008. The regulations relating to eligible automatic contribution arrangements (§§ 1.402(c)–2, 1.411(a)–4, 1.414(w)–1, and 54.4979–1) apply for plan years beginning on or after January 1, 2010. FOR FURTHER INFORMATION CONTACT: R. Lisa Mojiri-Azad, Dana Barry, or William D. Gibbs at (202) 622–6060 (not a toll-free number). SUPPLEMENTARY INFORMATION: Paperwork Reduction Act The collection of information contained in these final regulations has been reviewed and approved by the Office of Management and Budget in accordance with the Paperwork Reduction Act of 1995 (44 U.S.C. 3507(d)) under control number 1545– 2135 . The collection of information in these final regulations is in §§ 1.401(k)–3 and 1.414(w)–1. The information in § 1.401(k)–3 is required to comply with the statutory notice requirements in sections 401(k)(13) and 401(m)(12), and is expected to be included in the notices currently provided to employees that inform them of their rights and benefits under the plan. The collection of information under § 1.414(w)–1 is required to comply with the statutory notice requirements of section 414(w) and is expected to be included in the notices currently provided to employees E:\FR\FM\24FER1.SGM 24FER1

Agencies

[Federal Register Volume 74, Number 35 (Tuesday, February 24, 2009)]
[Rules and Regulations]
[Page 8200]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-3831]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 17

[Docket No. FDA-2008-N-0561]


Maximum Civil Money Penalty Amounts and Compliance With the 
Federal Civil Penalties Inflation Adjustment Act; Confirmation of 
Effective Date

AGENCY: Food and Drug Administration, HHS.

ACTION: Direct final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is confirming the 
effective date of March 27, 2009, for the direct final rule that 
appeared in the Federal Register of November 12, 2008 (73 FR 66750). 
The direct final rule amends the agency's regulations to update the 
statutory citations regarding the new civil monetary penalties 
prescribed by the Food and Drug Administration Amendments Act of 2007 
(FDAAA), amends the regulations to include the new FDAAA penalties, and 
adjusts the preceding maximum civil penalty amounts for inflation as 
prescribed by the Federal Civil Penalties Inflation Adjustment Act of 
1990 (FCPIAA). This document confirms the effective date of the direct 
final rule.

DATES: Effective date confirmed: March 27,2009.

FOR FURTHER INFORMATION CONTACT: Erik Mettler, Office of Policy, Food 
and Drug Administration, 10903 New Hampshire Ave, Bldg. 1, rm. 4305, 
Silver Spring, MD 20993, 301-796-4830.

SUPPLEMENTARY INFORMATION: In the Federal Register of November 12, 2008 
(73 FR 66750), FDA published the ``Maximum Civil Money Penalty Amounts 
and Compliance With the Federal Civil Penalties Inflation Adjustment 
Act'' direct final rule and solicited comments concerning the direct 
final rule for a 75-day period ending March 27, 2009. The direct final 
rule revises Sec.  17.1 (21 CFR 17.1) to update the statutory citations 
regarding the new civil monetary penalties prescribed by FDAAA, and 
revises the table in Sec.  17.2 (21 CFR 17.2) to include the new FDAAA 
penalties, and adjusts the preceding maximum civil penalty amounts for 
inflation as prescribed by the FCPIAA. This was accomplished by 
revising the list of statutory monetary penalties in Sec.  17.1 to 
include the new penalties prescribed by the Federal Food, Drug, and 
Cosmetic Act, as amended by FDAAA in 2007. These new penalties have 
been added as new paragraphs (c) and (d). The table in Sec.  17.2 also 
has been amended to include the new penalties, and the adjusted maximum 
penalty amounts for the pre-FDAAA penalties have been updated to 
account for the inflation between June 2004 (the year of the last 
adjustment) and June 2007 as prescribed by FCPIAA.
    FDA also solicited comments concerning the changes for a 75-day 
period ending January 26, 2009, in a proposed rule published in the 
Federal Register of November 12, 2008 (73 FR 66811). FDA stated that 
the effective date of the direct final rule would be on March 27, 2009, 
60 days after the end of the comment period, unless any significant 
adverse comment was submitted to FDA during the comment period. FDA did 
not receive any significant adverse comments.
    Authority: Therefore, under the Federal Food, Drug, and Cosmetic 
Act and the Public Health Service Act, and under authority delegated to 
the Commissioner of Food and Drugs, 21 CFR part 17 is amended. 
Accordingly, the amendments issued thereby are effective.

    Dated: February 17, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-3831 Filed 2-23-09; 8:45 am]
BILLING CODE 4160-01-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.